Pyc.asx

Market data is provided and pyc.asx by Thomson Reuters and Morningstar. Click for restrictions.

Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership. Please contact Member Services on support investsmart.

Pyc.asx

Driven to transform the lives of patients through a new generation of RNA therapeutics. PYC Therapeutics combines world-leading RNA therapeutic drug design with a revolutionary delivery technology based on a proprietary library of naturally derived Cell Penetrating Peptides CPPs to solve the delivery challenge associated with traditional RNA therapeutics. PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Our Platform is highly versatile and modular, offering broad potential across therapeutic areas. PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Truly Life-Changing Science. Latest Announcements. View all. We discover and develop RNA therapies to change the lives of patients with genetic diseases. Our Science. Disease areas PYC has a initial focus on ophthalmology, neurodevelopmental and kidney diseases and aims to apply its platform technology to further indications. Life-Changing Science PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. Stay Connected. Subscribe to our mailing list:.

Create new password.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets. Show more Opinion link Opinion. Show more Personal Finance link Personal Finance.

Pyc.asx

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company, which offers ribonucleic acid RNA therapeutics in patients with unmeet genetic diseases. The Company develops a pi peline of therapies, including two programs, which are focused on inherited eye diseases and preclinical discovery programs, which are focused on neurodegenerative and kidney diseases. Its preclinical, clinical, regulatory and corporate operations are based in San Diego, California. The Company's discovery and laboratory operations are located in Australia. Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech.

Craiglist minneapolis

The Company utilises its drug delivery platform to enhance the potency of precision medicines within the growing and commercially proven RNA therapeutic class. What our members say about us. Your password should be characters Invalid password: this word has been flagged as unsuitable for use as a secure password. Corporate governance. Upgrade Today. Thank you for registering. Is PYC's price volatile compared to industry and market? Resend code. How do PYC Therapeutics's earnings and revenue compare to its market cap? Investment options. Papyrus Australia. Information Services. The code you entered is incorrect. Please wait. Please select a quantity for at least one ticket.

PYC Therapeutics Limited.

Our Science. All rights reserved. PYC's goal is to provide patients with no current treatment options a therapeutic that addresses the underlying cause of the disease. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. An account with your email already exists. You might already have an ASX account with another platform. Actions Add to watchlist Add to portfolio Add an alert. Click here. Show more Markets link Markets. Our Board. Investment options.